Apposite Capital: Ready to Take the Lead in Life Science Investments
May 2008
Apposite Capital: Ready to Take the Lead in Life Science Investments
In this interview, Fintan Walton talks to Dr. Allan Marchington, partner in Apposite Capital.
Apposite Capital: Ready to Take the Lead in Life Science Investments
In this interview, Fintan Walton talks to Dr. Allan Marchington, partner in Apposite Capital, an independent single sector fund located in London but established with funding from the Mizuho Financial Group, one of Japan’s largest financial services company. Focusing on health care services in the UK and on life sciences in Europe and the U.S., Apposite uses their well-established network of executives and entrepreneurs to first identify and then to take the lead as early stage investors. A nine year fund, Apposite is endowed with $200 million to invest and, to date, have invested about 50% of their fund. Dr. Marchington shares that their success is built on their systematic approach to identifying areas of investment, their diligent efforts to work closely with early-stage companies, and their top-notch Advisory Board selected from some of the world’s top pharma companies.
Allan Marchington
Dr. Allan Marchington is a partner in Apposite Capital and is responsible for Apposite's Life Sciences investments. A partner since its inception, Dr. Marchington is a well-known executive in the pharmaceuticals sector and previously worked at Abingworth Management, where he was responsible for strategic changes at several of their portfolio companies. He joined Abingworth in 2003, from Millennium Pharmaceuticals, Cambridge MA, where as a member of the senior management team he was responsible for Millennium's European activities and all of the company's technology investments. Prior to Millennium, Dr. Marchington was principal founder and CEO of Cambridge Combinatorial, a combinatorial chemistry company that was acquired by Millennium for a substantial multiple of invested capital. He has a PhD in Chemistry from the University of Liverpool.
Apposite Capital
Apposite is a single sector fund investing in both life sciences and healthcare services on an international basis. Based in London, Apposite was established by the Mizuho Financial Group, one of Japan's largest financial services companies. The members of the Apposite team have a highly synergistic mix of healthcare venture/private equity, entrepreneurship, management and investment banking experience spanning many decades. Apposite also benefits from an established global network of leading advisors covering all aspects of the global healthcare market. The fund's strategy is to leverage the capabilities of the team and its advisors, combined with the fund's extensive range of contacts in Japan, Europe and the US to continuously add value to its portfolio companies.
